ClinicalTrials.gov
public full text
Public Domain
Somatuline Predictive Factors in Acromegaly and NET
The aim of the study is to identify predictive factors for the response to Lanreotide treatment in Acromegaly as well as in Neuroendocrine Tumours.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery#979338
- ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly#980992
- Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs#1045102
- Prediction of Tumor Shrinkage in Acromegaly#1111360
- United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting#1096438
Record · ID 1075233
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive